Author/Creator: Taurelli Salimbeni, Beatrice - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Taurelli Salimbeni, Beatrice

1. Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape. Issue 12 (2nd December 2022)

Authors:: Uliano, Jacopo; Nicolò, Eleonora; Corvaja, Carla; Taurelli Salimbeni, Beatrice; Trapani, Dario; Curigliano, Giuseppe
Journal:: Expert review of clinical pharmacology
Issue:: Volume 15:Issue 12(2022)
Page Start:: 1399
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance. (2nd November 2022)

Authors:: Corvaja, Carla; Taurelli Salimbeni, Beatrice; Nicolò, Eleonora; Puglisi, Fabio; Curigliano, Giuseppe
Journal:: Expert opinion on pharmacotherapy
Issue:: Volume 23:Number 16(2022)
Page Start:: 1765
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC. Issue 4 (31st March 2021)

Authors:: Rossi, Alessandro; Filetti, Marco; Taurelli Salimbeni, Beatrice; Piras, Marta; Rizzo, Francesco; Giusti, Raffaele; Marchetti, Paolo
Journal:: Cancer reports
Issue:: Volume 4:Issue 4(2021)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. The triple negative breast cancer drugs graveyard: a review of failed clinical trials 2017-2022. (2nd November 2022)

Authors:: Taurelli Salimbeni, Beatrice; Corvaja, Carla; Valenza, Carmine; Zagami, Paola; Curigliano, Giuseppe
Journal:: Expert opinion on investigational drugs
Issue:: Volume 31:Number 11(2022)
Page Start:: 1203
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗